Breakthrough blood test detects brain cancers in just 60 minutes
A new quicker and less invasive method for brain cancer detection has been developed as an alternative to surgical biopsy, boasting detection rates of just one hour.
This advancement was achieved by a joint team from both the US and Australia, headed by researchers from the University of Notre Dame (IN, United States). Their innovative ‘liquid biopsy’ requires just 100 microliters of blood and can identify biomarkers linked to glioblastoma (GBM), the most common and lethal brain tumor, within an hour. The novel method is a huge step forward for brain cancer diagnosis and currently surpasses all other presently available tests and markers for GBM, coupled with high accuracy.
